Study to Assess the Pharmacokinetics, Safety and Tolerability of Baloxavir Marboxil in Healthy Chinese Participants

Inclusion criteria

• Chinese participants must have Chinese parents and grandparents, all of whom were born in China.
• Healthy status as defined by absence of evidence of any active or chronic disease
• Participants whose body weight is ≥50 to <80 kg and body mass index is ≥18.5 to <26 kg/m2

Exclusion criteria

• Participants with a history of stomach, vagus nerve, or intestinal surgery (except for appendectomy)
• Participants who have a history of allergic symptoms including food allergy (Note: Non-active allergic rhinitis will be allowed)
• Participants who require chronic drug therapy or those who have used drugs within 3 days prior to screening or within 14 days prior to Day -1
• Participants who have used alcohol-containing, caffeine-containing, grapefruit containing, or St. John's wort-containing products within 72 hours prior to Day -1
• Participants who have used tobacco- or nicotine-containing products within 24 weeks prior to screening
• Participants who have donated > 400 mL of blood within 12 weeks or > 200 mL of blood within 4 weeks prior to screening, or have donated any amount of blood between screening and Day -1